Although each 5T4 cancer antigen-reactive clone exhibited similar reactivity, this sensitivity was markedly inferior (∼100-fold weaker) to CD4+ T-cell clones recognizing pathogen-derived epitopes (representative example to IAV hemagglutinin306–319 epitope shown). Here, CD4 is linked to cancer.